Company & Sponsor Intelligence

Medical University of South Carolina

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials14

Recruiting3

Completed10

Countries1

Therapeutic footprint

adhdautismdepressionepilepsyother_psychiatrypain_neuropathyptsdstrokesubstance_use

Indexed studies

NCT06698328fMRI Tracking taVNS in ASD
autism · United StatesNA

NCT01573273Oxytocin in Cocaine Dependence
substance_use · United StatesNA

NCT00844701Cue Induced Imaging in Nicotine Dependent Smokers
other_psychiatry · United StatesCOMPLETED

NCT01363154Prevention of Photoparoxysmal Abnormalities by Mozart K448
epilepsy · United StatesNA

NCT06930729Optimizing Care for Cancer Survivors With Depression: Project 3
depression · United StatesNA

NCT00360269Atomoxetine Treatment for ADHD and Marijuana Dependence
adhd · United StatesPHASE2

NCT02939560TMS for Adults With Autism and Depression
autism · United StatesNA

NCT01338506Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
ptsd · United StatesNA

NCT02897687Facebook for Social Skills Training in Autism: Project Rex Connect
autism · United StatesNA

NCT01827332Effect of Oxytocin on Craving and Therapy Response
substance_use · United StatesNA

NCT06616831At-Home taVNS - Stroke Rehab
stroke · United StatesNA

NCT06894849Text -Based Depression Screening Among Cancer Survivors
depression · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →